Interaction between nonsynonymous polymorphisms in PLA2G7 gene and smoking on the risk of coronary heart disease in a Chinese population
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interaction between nonsynonymous polymorphisms in PLA2G7 gene and smoking on the risk of coronary heart disease in a Chinese population
Authors
Keywords
PLA2G7, Coronary heart disease, SNP, Interaction, Smoking, Drinking, Haplotype
Journal
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
Volume 46, Issue 1, Pages 125-130
Publisher
Springer Nature
Online
2018-05-04
DOI
10.1007/s11239-018-1671-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lipoprotein-associated phospholipase A2 and risk of incident cardiovascular disease in a multi-ethnic cohort: The multi ethnic study of atherosclerosis
- (2015) Parveen K. Garg et al. ATHEROSCLEROSIS
- Circulating concentrations of endothelin-1 predict coronary heart disease in women but not in men: a longitudinal observational study in the Vara-Skövde Cohort
- (2015) Bledar Daka et al. BMC Cardiovascular Disorders
- Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials
- (2015) Jessica L Mega et al. LANCET
- Nonsynonymous polymorphisms in PLA2G7 gene are associated with the risk of coronary heart disease in a southern Chinese population
- (2015) Mei Hong et al. MAMMALIAN GENOME
- Smoking Cessation, Weight Change, and Coronary Heart Disease Among Postmenopausal Women With and Without Diabetes
- (2013) Juhua Luo et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- National trend in congenital heart disease mortality in China during 2003 to 2010: A population-based study
- (2013) Zhan Hu et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- An association study between genetic polymorphisms related to lipoprotein-associated phospholipase A2 and coronary heart disease
- (2013) LIMIN XU et al. Experimental and Therapeutic Medicine
- Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments
- (2012) J.C. Charniot et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy
- (2012) I-Min Lee et al. LANCET
- Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease
- (2012) Wei Gao et al. Lipids in Health and Disease
- Association between Lipoprotein-Associated Phospholipase A2 Gene Polymorphism and Coronary Artery Disease in the Chinese Han Population
- (2011) Liyun Li et al. ANNALS OF HUMAN GENETICS
- PLA2G7 gene polymorphisms and coronary heart disease risk: A meta-analysis
- (2010) Qianqian Wang et al. THROMBOSIS RESEARCH
- Review of the Evidence for the Clinical Utility of Lipoprotein-Associated Phospholipase A2 as a Cardiovascular Risk Marker
- (2008) Marshall A. Corson et al. AMERICAN JOURNAL OF CARDIOLOGY
- Associations of PLA2G7 gene polymorphisms with plasma lipoprotein-associated phospholipase A2 activity and coronary heart disease in a Chinese Han population: the Beijing atherosclerosis study
- (2008) Liping Hou et al. HUMAN GENETICS
- Comprehensive genetic analysis of the platelet activating factor acetylhydrolase (PLA2G7) gene and cardiovascular disease in case–control and family datasets
- (2008) Beth S. Sutton et al. HUMAN MOLECULAR GENETICS
- Distribution and Correlates of Lipoprotein-Associated Phospholipase A2 in an Elderly Cohort: The Cardiovascular Health Study
- (2008) Curt D. Furberg et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More